Search
×
FR

Placeholder headline

This is just a placeholder headline

API MPMS CH 10.8, 3rd Edition: Standard Test Method for Sediment in Crude Oil by Membrane Filtration

$

114

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO/TR 42505:2026 Sharing economy — Shared manufacturing — Concepts and models

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 4306-1:2026 Cranes — Vocabulary — Part 1: General

$

436

BUY NOW

ISO 10993:2018

ISO 10993:2018 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process

CDN $364.00

SKU: f9bd999121f9 Categories: ,

Description

This document specifies:

– the general principles governing the biological evaluation of medical devices within a risk management process;

– the general categorization of medical devices based on the nature and duration of their contact with the body;

– the evaluation of existing relevant data from all sources;

– the identification of gaps in the available data set on the basis of a risk analysis;

– the identification of additional data sets necessary to analyse the biological safety of the medical device;

– the assessment of the biological safety of the medical device.

This document applies to evaluation of materials and medical devices that are expected to have direct or indirect contact with:

– the patient’s body during intended use;

– the user’s body, if the medical device is intended for protection (e.g., surgical gloves, masks and others).

This document is applicable to biological evaluation of all types of medical devices including active, non-active, implantable and non-implantable medical devices.

This document also gives guidelines for the assessment of biological hazards arising from:

– risks, such as changes to the medical device over time, as a part of the overall biological safety assessment;

– breakage of a medical device or medical device component which exposes body tissue to new or novel materials.

Other parts of ISO 10993 cover specific aspects of biological assessments and related tests. Device-specific or product standards address mechanical testing.

This document excludes hazards related to bacteria, moulds, yeasts, viruses, transmissible spongiform encephalopathy (TSE) agents and other pathogens.

Edition

5

Published Date

2018-08-17

Status

PUBLISHED

Pages

41

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document specifies:

- the general principles governing the biological evaluation of medical devices within a risk management process;

- the general categorization of medical devices based on the nature and duration of their contact with the body;

- the evaluation of existing relevant data from all sources;

- the identification of gaps in the available data set on the basis of a risk analysis;

- the identification of additional data sets necessary to analyse the biological safety of the medical device;

- the assessment of the biological safety of the medical device.

This document applies to evaluation of materials and medical devices that are expected to have direct or indirect contact with:

- the patient's body during intended use;

- the user's body, if the medical device is intended for protection (e.g., surgical gloves, masks and others).

This document is applicable to biological evaluation of all types of medical devices including active, non-active, implantable and non-implantable medical devices.

This document also gives guidelines for the assessment of biological hazards arising from:

- risks, such as changes to the medical device over time, as a part of the overall biological safety assessment;

- breakage of a medical device or medical device component which exposes body tissue to new or novel materials.

Other parts of ISO 10993 cover specific aspects of biological assessments and related tests. Device-specific or product standards address mechanical testing.

This document excludes hazards related to bacteria, moulds, yeasts, viruses, transmissible spongiform encephalopathy (TSE) agents and other pathogens.

Previous Editions

Can’t find what you are looking for?

Please contact us at: